Elevai Labs Statistics
Total Valuation
Elevai Labs has a market cap or net worth of $1.02 million. The enterprise value is -$5.27 million.
Important Dates
The last earnings date was Thursday, November 14, 2024, before market open.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Elevai Labs has 49.38 million shares outstanding. The number of shares has increased by 79.92% in one year.
| Current Share Class | 49.38M |
| Shares Outstanding | 49.38M |
| Shares Change (YoY) | +79.92% |
| Shares Change (QoQ) | +21.10% |
| Owned by Insiders (%) | 18.48% |
| Owned by Institutions (%) | 13.69% |
| Float | 36.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.15 |
| Forward PS | n/a |
| PB Ratio | 0.12 |
| P/TBV Ratio | 0.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.86, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.86 |
| Quick Ratio | 3.03 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.96 |
Financial Efficiency
Return on equity (ROE) is -130.35% and return on invested capital (ROIC) is -70.62%.
| Return on Equity (ROE) | -130.35% |
| Return on Assets (ROA) | -48.26% |
| Return on Capital (ROIC) | -70.62% |
| Revenue Per Employee | $135,898 |
| Profits Per Employee | -$303,829 |
| Employee Count | 18 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 0.95 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.10 |
| 200-Day Moving Average | 0.45 |
| Relative Strength Index (RSI) | 26.83 |
| Average Volume (20 Days) | 323,697,811 |
Short Selling Information
The latest short interest is 9.42 million, so 19.08% of the outstanding shares have been sold short.
| Short Interest | 9.42M |
| Short Previous Month | 1.87M |
| Short % of Shares Out | 19.08% |
| Short % of Float | 25.64% |
| Short Ratio (days to cover) | 1.33 |
Income Statement
In the last 12 months, Elevai Labs had revenue of $2.45 million and -$5.47 million in losses. Loss per share was -$0.31.
| Revenue | 2.45M |
| Gross Profit | 1.74M |
| Operating Income | -4.94M |
| Pretax Income | -4.62M |
| Net Income | -5.47M |
| EBITDA | -4.92M |
| EBIT | -4.94M |
| Loss Per Share | -$0.31 |
Full Income StatementBalance Sheet
The company has $6.43 million in cash and $103,309 in debt, giving a net cash position of $6.32 million or $0.13 per share.
| Cash & Cash Equivalents | 6.43M |
| Total Debt | 103,309 |
| Net Cash | 6.32M |
| Net Cash Per Share | $0.13 |
| Equity (Book Value) | 8.56M |
| Book Value Per Share | 0.17 |
| Working Capital | 6.10M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$5.87 million and capital expenditures -$9,160, giving a free cash flow of -$5.88 million.
| Operating Cash Flow | -5.87M |
| Capital Expenditures | -9,160 |
| Free Cash Flow | -5.88M |
| FCF Per Share | -$0.12 |
Full Cash Flow StatementMargins
Gross margin is 71.15%, with operating and profit margins of -201.82% and -223.57%.
| Gross Margin | 71.15% |
| Operating Margin | -201.82% |
| Pretax Margin | -223.57% |
| Profit Margin | -223.57% |
| EBITDA Margin | -201.31% |
| EBIT Margin | -201.82% |
| FCF Margin | n/a |